Flow cytometry analysis of the effect of allopurinol and the dinitroaniline compound (Chloralin) on the viability and proliferation of Leishmania infantum promastigotes

BMC Pharmacology

Volumn 1, Issue , 2001, Pages

  Kamau, Sarah W ^a   Nunez, Rafael ^a,b   Grimm, Felix ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 CHLORO 3,5 DINITROBENZOTRIFLUORIDE; ALLOPURINOL; ANILINE DERIVATIVE; ANTIPARASITIC AGENT; CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; PROPIDIUM IODIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL DEATH; CELL DIVISION; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; CULTURE MEDIUM; DENSITY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG EXPOSURE; DRUG MECHANISM; EXPERIMENTAL MODEL; FLOW CYTOMETRY; IN VITRO STUDY; INCUBATION TIME; LEISHMANIA INFANTUM; MEDICAL ASSESSMENT; MEMBRANE PERMEABILITY; NONHUMAN; PROMASTIGOTE; QUANTITATIVE ANALYSIS;

EID: 2642510791     PISSN: 14712210     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2210-1-1     Document Type: Article

References (36)

1. World Health Organization. Leishmania-HIV co-infection. Epidemiological analysis of 692 retrospective cases. Weekly Epidemiological Records. 1997, 72:49-54
2. Dedet JP, Lambert M, Pratlong F: Leishmaniasis and human immunodeficiency virus infections. Presse Med. 1995, 24(22):1036-40
3. Montalban C, Calleja JL, Erice A, Laguna F, Clotet B, Podzamczer D, Cobo J, Mallolas J, Yebra M, Gallego A: Visceral leishmaniasis in patients infected with human immunodeficiency virus. Cooperative Group for the Study of Leishmaniasis in AIDS. J Infect. 1990, 21(3):261-70
4. Alvar J, Canavate C, Gutierrez-Solar B, Jimenez M, Laguna F, Lopez-Velez R, Molina R, Moreno J: Leishmania and human immunodeficiency virus coinfection: the first 10 years. Clin Microbiol Rev. 1997, 10(2):298-319
5. Moreno J, Canavate C, Chamizo C, Laguna F, Alvar J: HIV - Leishmania infantum co-infection: humoral and cellular immune responses to the parasite after chemotherapy. Trans R Soc Trop Med Hyg. 2000, 94(3):328-32
6. Baneth G, Dank G, Keren-Kornblatt E, Sekeles E, Adini I, Eisenberger CL, Schnur LF, King R, Jaffe CL: Emergence of visceral leishmaniasis in central Israel. Am J Trop Med Hyg. 1998, 59(5):722-5
7. Ben Ismail R, Gradoni L, Gramiccia M, Bettini S, Ben Rachid MS, Garraoui A: Epidemic cutaneous leishmaniasis in Tunisia: biochemical characterization of parasites. Trans R Soc Trop Med Hyg. 1986, 80(4):669-70
8. Sellon RK, Menard MM, Meuten DJ, Lengerich EJ, Steurer FJ, Breitschwerdt EB: Endemic visceral leishmaniasis in a dog from Texas. J Vet Intern Med. 1993, 7(1):16-9
9. Eddlestone SM: Visceral leishmaniasis in a dog from Maryland. J Am Vet Med Assoc. 2000, 217(11):1659-1688
10. Ouellette M, Legare D, Papadopoulou B: Microbial multidrug-resistance ABC transporters. Trends Microbiol. 1994, 2(10):407-11
11. Herwaldt BL: Miltefosine - the long-awaited therapy for visceral leishmaniasis? N Engl J Med. 1999, 341(24):1840-2
12. Jha TK, Sundar S, Thakur CP, Bachmann P, Karbwang J, Fischer C, Voss A, Berman J: Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis. N Engl J Med. 1999, 341(24):1795-800
13. Le Fichoux Y, Rousseau D, Ferrua B, Ruette S, Lelievre A, Grousson D, Kubar J: Short- and long-term efficacy of hexadecylphosphocholine against established Leishmania infantum infection in BALB/c mice. Antimicrob Agents Chemother. 1998 42(3):654-8.
14. Cavaliero T, Arnold P, Mathis A, Glaus T, Hofmann-Lehmann R, Deplazes P: Clinical, serologic, and parasitologic follow-up after long-term allopurinol therapy of dogs naturally infected with Leishmania infantum. J Vet Intern Med. 1999, 13(4):330-4
15. Liste F, Gascon M: Allopurinol in the treatment of canine visceral leishmaniasis. Vet Rec. 1995, 137(1):23-4
16. Denerolle P, Bourdoiseau G: Combination allopurinol and antimony treatment versus antimony alone and allopurinol alone in the treatment of canine leishmaniasis (96 cases). J Vet Intern Med. 1999, 13(5):413-5
17. Armson A, Kamau SW, Grimm F, Reynoldson JA, Best WM, MacDonald LM, Thompson RC: A comparison of the effects of a benzimidazole and the dinitroanilines against Leishmania infantum. Acta Trop. 1999, 73(3):303-11
18. Callahan HL, Kelley C, Pereira T, Grogl M: Microtubule inhibitors: structure-activity analyses suggest rational models to identify potentially active compounds. Antimicrob Agents Chemother. 1996, 40(4):947-52
19. Katiyar SK, Edlind TD: Beta-tubulin genes of Trichomonas vaginalis. Mol Biochem Parasitol. 1994, 64(1):33-42
20. Meloni BP, Thompson RC, Reynoldson JA, Seville P: Albendazole: a more effective antigiardial agent in vitro than metronidazole or tinidazole. Trans R Soc Trop Med Hyg. 1990, 84(3):375-9
21. Chan MM, Grogl M, Chen CC, Bienen EJ, Fong D: Herbicides to curb human parasitic infections: in vitro and in vivo effects of trifluralin on the trypanosomatid protozoans. Proc Natl Acad Sci U S A. 1993, 90(12):5657-61
22. Chan MM, Grogl M, Callahan H, Fong D: Efficacy of the herbicide trifluralin against four P-glycoprotein-expressing strains of Leishmania. Antimicrob Agents Chemother. 1995, 39(7):1609-11
23. Carrio J, de Colmenares M, Riera C, Gallego M, Arboix M, Portus M: Leishmania infantum: stage-specific activity of pentavalent antimony related with the assay conditions. Exp Parasitol. 2000, 95(3):209-14
24. Callahan HL, Portal AC, Devereaux R, Grogl M: An axenic amastigote system for drug screening. Antimicrob Agents Chemother. 1997, 41(4):818-22
25. Sereno D, Cavaleyra M, Zemzoumi K, Maquaire S, Ouaissi A, Lemesre JL: Axenically grown amastigotes of Leishmania infantum used as an in vitro model to investigate the pentavalent antimony mode of action. Antimicrob Agents Chemother. 1998, 42(12):3097-102
26. Sereno D, Holzmuller P, Lemesre JL: Efficacy of second line drugs on antimonyl-resistant amastigotes of Leishmania infantum. Acta Trop. 2000, 74(1):25-31
27. Lyons AB, Parish CR: Determination of lymphocyte division by flow cytometry. J Immunol Methods. 1994, 171(1):131-7
28. Haugland RP: Handbook of Fluorescent Probes and Research Chemicals. Eugene: Molecular Probes Inc. 1992,
29. Ueckert JE, Nebe von-Caron G, Bos AP, ter Steeg PF: Flow cytometric analysis of Lactobacillus plantarum to monitor lag times, cell division and injury. Lett Appl Microbiol. 1997, 25(4):295-9
30. Kamau SW, Hurtado M, Muller-Doblies UU, Grimm F, Nunez R: Flow cytometric assessment of allopurinol susceptibility in Leishmania infantum promastigote. Cytometry. 2000, 40(4):353-60
31. Nunez R., Kamau S., Grimm F: Flow Cytometric assessment of drug susceptibility in Leishmania infantum Promastigote. Unit 11.14 in Robinson J.P., Darzynkiewicz Z., Dean P., Orfao A., Rabinovitch P., Tanke H., Wheeless L. eds. Current protocols in Cytometry. New York: John Wiley & Sons, Inc. 2001, Supplement 16:Unit 11.14-32.
32. Garner DL, Johnson LA, Yue ST, Roth BL, Haugland RP: Dual DNA staining assessment of bovine sperm viability using SYBR-14 and propidium iodide. J Androl. 1994, 15(6):620-9
33. Marr JJ, Berens RL: Pyrazolopyrimidine metabolism in the pathogenic trypanosomatidae. Mol Biochem Parasitol. 1983, 7(4):339-56
34. Marr JJ: Purine analogs as chemotherapeutic agents in leishmaniasis and American trypanosomiasis. J Lab Clin Med. 1991, 118(2):111-9
35. Frayha GJ, Smyth JD, Gobert JG, Savel J: The mechanisms of action of antiprotozoal and anthelmintic drugs in man. Gen Pharmacol. 1997, 28(2):273-99
36. Grimm F, Brun R, Jenni L: Promastigote infectivity in Leishmania infantum. Parasitol Res. 1991, 77(3):185-91